Reference
National Institute for Health and Care Excellence (NICE). NICE draft guidance recommends abemaciclib for advanced breast cancer. Internet Document : 17 Aug 2021. Available from: URL: https://www.nice.org.uk/news/article/nice-draft-guidance-recommends-abemaciclib-for-advanced-breast-cancer
Rights and permissions
About this article
Cite this article
UK's NICE has recommended abemaciclib for advanced breast cancer in draft guidance. PharmacoEcon Outcomes News 885, 36 (2021). https://doi.org/10.1007/s40274-021-07978-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-07978-8